Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy

Published:2018-08 Issue: Volume:188 Page:168-175
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Lu Yanxin,Liu Yang,Pang Ying,Pacak Karel,Yang Chunzhang

Funder

National Institutes of Health

Council for Chemical Research

National Cancer Institute

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference94 articles.

1. In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma;AlHilli;Gynecologic Oncology,2016

2. The PARP superfamily;Ame;BioEssays,2004

3. A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair;Ashworth;Journal of Clinical Oncology,2008

4. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial;Audeh;Lancet,2010

5. Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy;Aziz;Pharmacology & Therapeutics,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer;Frontiers in Oncology;2024-08-02

2. Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities;European Journal of Medicinal Chemistry;2023-11

3. Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma;Science Translational Medicine;2023-11

4. A universal programmable Gaussian boson sampler for drug discovery;Nature Computational Science;2023-10-12

5. DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review;Pharmacological Research;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3